J
Jenny L Donovan
Researcher at University of Bristol
Publications - 586
Citations - 44316
Jenny L Donovan is an academic researcher from University of Bristol. The author has contributed to research in topics: Prostate cancer & Randomized controlled trial. The author has an hindex of 100, co-authored 562 publications receiving 39131 citations. Previous affiliations of Jenny L Donovan include University of Tampere & Southmead Hospital.
Papers
More filters
Journal ArticleDOI
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Minh-Phuong Huynh-Le,Chun Chieh Fan,Roshan Karunamuni,Wesley K. Thompson,Maria Elena Martinez,Rosalind A. Eeles,Zsofia Kote-Jarai,Kenneth Muir,Kenneth Muir,Johanna Schleutker,Johanna Schleutker,Nora Pashayan,Nora Pashayan,Jyotsna Batra,Jyotsna Batra,Henrik Grönberg,David E. Neal,David E. Neal,Jenny L Donovan,Freddie C. Hamdy,Freddie C. Hamdy,Richard M. Martin,Richard M. Martin,Richard M. Martin,Sune F. Nielsen,Sune F. Nielsen,Børge G. Nordestgaard,Børge G. Nordestgaard,Fredrik Wiklund,Catherine M. Tangen,Graham G. Giles,Graham G. Giles,Graham G. Giles,Alicja Wolk,Alicja Wolk,Demetrius Albanes,Ruth C. Travis,William J. Blot,Wei Zheng,Maureen Sanderson,Janet L. Stanford,Janet L. Stanford,Lorelei A. Mucci,Catharine M L West,Adam S. Kibel,Olivier Cussenot,Sonja I. Berndt,Stella Koutros,Karina Dalsgaard Sørensen,Karina Dalsgaard Sørensen,Cezary Cybulski,Eli Marie Grindedal,Florence Menegaux,Florence Menegaux,Kay-Tee Khaw,Jong Y. Park,Sue A. Ingles,Christiane Maier,Robert J. Hamilton,Robert J. Hamilton,Stephen N. Thibodeau,Barry S. Rosenstein,Yong-Jie Lu,Stephen Watya,Ana Vega,Manolis Kogevinas,Kathryn L. Penney,Chad D. Huff,Manuel R. Teixeira,Luc Multigner,Robin J. Leach,Lisa A. Cannon-Albright,Lisa A. Cannon-Albright,Hermann Brenner,Esther M. John,Radka Kaneva,Christopher J. Logothetis,Susan L. Neuhausen,Kim De Ruyck,Hardev Pandha,Azad Hassan Abdul Razack,Lisa F. Newcomb,Lisa F. Newcomb,Jay H. Fowke,Jay H. Fowke,Marija Gamulin,Nawaid Usmani,Nawaid Usmani,Frank Claessens,Manuela Gago-Dominguez,Paul A. Townsend,William S. Bush,Monique J. Roobol,Marie-Élise Parent,Marie-Élise Parent,Jennifer J. Hu,Ian G. Mills,Ole A. Andreassen,Anders M. Dale,Tyler M. Seibert,Apcb,Nc-La PCaP Investigators,Canary Pass Investigators +102 more
TL;DR: In this paper, a polygenic hazard score (PHS2) is associated with age at diagnosis of any and aggressive prostate cancer, stage T3-T4, PSA ≥ 10 ng/mL or nodal/distant metastasis.
Journal ArticleDOI
Validation of the Bluebelle Wound Healing Questionnaire for assessment of surgical‐site infection in closed primary wounds after hospital discharge
Rhiannon C Macefield,Jane M Blazeby,Barnaby C Reeves,Sara T Brookes,Kerry N L Avery,Chris A Rogers,Mark Woodward,Nicky J Welton,Leila Rooshenas,Jonathan Mathers,A. Torrance,Anne Pullyblank,Robert J Longman,Richard Lovegrove,Tim Draycott,Thomas Pinkney,Rachael Gooberman-Hill,Jenny L Donovan,Joanna Coast,Melanie Calvert,Natalie S Blencowe,Lazaros Andronis,Dimitrios Siassakos,Caroline Pope,Madeleine Clout,Kate Ashton,Lucy Ellis,Christel McMullan,Rosie A Harris,Daisy Elliott,Jo C Dumville,Benjamin R. Waterhouse,Sean Strong,William Seligman,Lloyd Rickard,Samir Pathak,Anwar Owais,Jamie O’Callaghan,Stephen O'Brien,Dmitri Nepogodiev,Khaldoun Nadi,Charlotte E Murkin,Tonia Munder,Tom Milne,David E. Messenger,Matthew Mason,Morwena Marshall,Jessica Lloyd,Jeffrey Lim,Kathryn Lee,Vijay Korwar,Daniel Hughes,George Hill,Mohammed Hamdan,Hannah Gould Brown,James Glasbey,Caroline Fryer,Simon Davey,David Cotton,Benjamin E Byrne,O. Brown,Katarzyna Bera,Joanne Bennett,Richard Bamfor,Danya Bakhbakhi,Muhammad Atif,Elizabeth Armstrong,Piriyankan Ananthavarathan +67 more
TL;DR: The Bluebelle Wound Healing Questionnaire was developed for patient or observer completion; this study tested its acceptability, scale structure, reliability and validity in patients with closed primary wounds after abdominal surgery.
Journal ArticleDOI
Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study
Anya J. Burton,Richard M. Martin,Jeffrey M P Holly,J A Lane,Jenny L Donovan,Freddie C. Hamdy,David E. Neal,Kate Tilling +7 more
TL;DR: There is some evidence that adiponectin levels may be associated with prostate cancer stage, dependent on the degree of adiposity of the man, consistent with adip onectin countering the adverse effects of obesity on prostate cancer progression.
Journal ArticleDOI
Comparing open and minimally invasive surgical procedures for oesophagectomy in the treatment of cancer: the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) feasibility study and pilot trial.
Chris Metcalfe,Kerry N L Avery,Richard G. Berrisford,Paul Barham,Sian M Noble,Aida Moure Fernandez,George B. Hanna,Robert D. Goldin,Jackie Elliott,T Wheatley,Grant Sanders,Andrew Hollowood,Stephen Falk,Dan Titcomb,Christopher Streets,Jenny L Donovan,Jane M Blazeby,Jane M Blazeby +17 more
TL;DR: The ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) study as discussed by the authors aimed to establish the feasibility of, and methodology for, a definitive trial comparing minimally invasive and open surgery.
Journal ArticleDOI
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Freddie C. Hamdy,Jenny L Donovan,J. Athene Lane,Malcolm David Mason,Chris Metcalfe,Peter Holding,Julia Wade,Sian Noble,Kirsty Garfield,Grace J. Young,Michael Davis,Tim J Peters,Emma L Turner,Richard M. Martin,Jon Oxley,M.C. Robinson,John Staffurth,Eleanor I Walsh,Jane M Blazeby,Richard J. Bryant,Prasad Bollina,James W.F. Catto,Andrew Doble,Alan Doherty,David Gillatt,Vincent J. Gnanapragasam,Owen Hughes,Roger Kockelbergh,Howard Kynaston,Alan Paul,Edgar Paez,Philip Powell,Stephen Prescott,Derek J. Rosario,Edward Rowe,David E. Neal +35 more
TL;DR: A prospective, multicentre prostate-specific antigen testing programme followed by a randomised trial of treatment, with a comprehensive cohort follow-up, to evaluate the effectiveness of conventional treatments for localised prostate cancer in men aged 50-69 years.